262 related articles for article (PubMed ID: 25089569)
1. C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin β1 glycosylation and activity.
Liu CH; Hu RH; Huang MJ; Lai IR; Chen CH; Lai HS; Wu YM; Huang MC
PLoS One; 2014; 9(8):e94995. PubMed ID: 25089569
[TBL] [Abstract][Full Text] [Related]
2. C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.
Wu YM; Liu CH; Huang MJ; Lai HS; Lee PH; Hu RH; Huang MC
Cancer Res; 2013 Sep; 73(17):5580-90. PubMed ID: 23832667
[TBL] [Abstract][Full Text] [Related]
3. C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin α
Kuo TC; Wu MH; Yang SH; Chen ST; Hsu TW; Jhuang JY; Liao YY; Tien YW; Huang MC
Oncogene; 2021 Feb; 40(7):1242-1254. PubMed ID: 33420364
[TBL] [Abstract][Full Text] [Related]
4. C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2.
Hung JS; Huang J; Lin YC; Huang MJ; Lee PH; Lai HS; Liang JT; Huang MC
Oncotarget; 2014 Apr; 5(8):2096-106. PubMed ID: 24758762
[TBL] [Abstract][Full Text] [Related]
5. Altered O-glycosylation is associated with inherent radioresistance and malignancy of human laryngeal carcinoma.
Dong X; Luo Z; Wang Y; Meng L; Duan Q; Qiu L; Peng F; Shen L
Exp Cell Res; 2018 Jan; 362(2):302-310. PubMed ID: 29179977
[TBL] [Abstract][Full Text] [Related]
6. miR-9 inhibits the metastatic ability of hepatocellular carcinoma via targeting beta galactoside alpha-2,6-sialyltransferase 1.
Han Y; Liu Y; Fu X; Zhang Q; Huang H; Zhang C; Li W; Zhang J
J Physiol Biochem; 2018 Aug; 74(3):491-501. PubMed ID: 30006781
[TBL] [Abstract][Full Text] [Related]
7. N-glycosylation by N-acetylglucosaminyltransferase IVa enhances the interaction of integrin β1 with vimentin and promotes hepatocellular carcinoma cell motility.
Yang D; Han F; Cai J; Sun H; Wang F; Jiang M; Zhang M; Yuan M; Zhou W; Li H; Yang L; Bai Y; Xiao L; Dong H; Cheng Q; Mao H; Zhou L; Wang R; Li Y; Nie H
Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119513. PubMed ID: 37295747
[TBL] [Abstract][Full Text] [Related]
8. C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer.
Lin MC; Chien PH; Wu HY; Chen ST; Juan HF; Lou PJ; Huang MC
Oncogene; 2018 Oct; 37(43):5780-5793. PubMed ID: 29930379
[TBL] [Abstract][Full Text] [Related]
9. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.
Lee PC; Chen ST; Kuo TC; Lin TC; Lin MC; Huang J; Hung JS; Hsu CL; Juan HF; Lee PH; Huang MC
Oncogene; 2020 Mar; 39(13):2724-2740. PubMed ID: 32005975
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway.
Chou CH; Huang MJ; Chen CH; Shyu MK; Huang J; Hung JS; Huang CS; Huang MC
Oncotarget; 2015 Mar; 6(8):6123-35. PubMed ID: 25762620
[TBL] [Abstract][Full Text] [Related]
11. β-1,4-Galactosyltransferase III suppresses β1 integrin-mediated invasive phenotypes and negatively correlates with metastasis in colorectal cancer.
Chen CH; Wang SH; Liu CH; Wu YL; Wang WJ; Huang J; Hung JS; Lai IR; Liang JT; Huang MC
Carcinogenesis; 2014 Jun; 35(6):1258-66. PubMed ID: 24403309
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of C1GalT1 inhibits radioresistance of human esophageal cancer cells through modifying β1-integrin glycosylation.
Zhang C; Deng X; Qiu L; Peng F; Geng S; Shen L; Luo Z
J Cancer; 2018; 9(15):2666-2677. PubMed ID: 30087707
[TBL] [Abstract][Full Text] [Related]
13. Extracellular membrane-proximal domain of HAb18G/CD147 binds to metal ion-dependent adhesion site (MIDAS) motif of integrin β1 to modulate malignant properties of hepatoma cells.
Li Y; Wu J; Song F; Tang J; Wang SJ; Yu XL; Chen ZN; Jiang JL
J Biol Chem; 2012 Feb; 287(7):4759-72. PubMed ID: 22130661
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA‑3653 inhibits the growth and metastasis of hepatocellular carcinoma by inhibiting ITGB1.
Zhang L; Zhang T; Deng Z; Sun L
Oncol Rep; 2019 Mar; 41(3):1669-1677. PubMed ID: 30664185
[TBL] [Abstract][Full Text] [Related]
15. Effect of fibulin-5 on adhesion, migration and invasion of hepatocellular carcinoma cells via an integrin-dependent mechanism.
Tang JC; Liu JH; Liu XL; Liang X; Cai XJ
World J Gastroenterol; 2015 Oct; 21(39):11127-40. PubMed ID: 26494967
[TBL] [Abstract][Full Text] [Related]
16. β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma.
Chang HH; Chen CH; Chou CH; Liao YF; Huang MJ; Chen YH; Wang WJ; Huang J; Hung JS; Ho WL; Jeng YM; Che MI; Lee H; Lu MY; Yang YL; Jou ST; Lin DT; Lin KH; Hsu WM; Huang MC
Clin Cancer Res; 2013 Apr; 19(7):1705-16. PubMed ID: 23444218
[TBL] [Abstract][Full Text] [Related]
17. ADAM17 promotes cell migration and invasion through the integrin β1 pathway in hepatocellular carcinoma.
Li Y; Ren Z; Wang Y; Dang YZ; Meng BX; Wang GD; Zhang J; Wu J; Wen N
Exp Cell Res; 2018 Sep; 370(2):373-382. PubMed ID: 29966664
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of CTHRC1 in hepatocellular carcinoma promotes tumor invasion and predicts poor prognosis.
Chen YL; Wang TH; Hsu HC; Yuan RH; Jeng YM
PLoS One; 2013; 8(7):e70324. PubMed ID: 23922981
[TBL] [Abstract][Full Text] [Related]
19. HAb18G/CD147 promotes radioresistance in hepatocellular carcinoma cells: a potential role for integrin β1 signaling.
Wu J; Li Y; Dang YZ; Gao HX; Jiang JL; Chen ZN
Mol Cancer Ther; 2015 Feb; 14(2):553-63. PubMed ID: 25534361
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor enhances cell adhesion and decreases cell migration via modulating β1-integrin-AKT signaling in hepatocellular carcinoma cells.
Ma WL; Jeng LB; Lai HC; Liao PY; Chang C
Cancer Lett; 2014 Aug; 351(1):64-71. PubMed ID: 24944078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
